Martin Bodingbauer
Associate Professor
Department of Surgery (Division of General Surgery)
Medical University of Vienna
Austria
Biography
Dr. Martin Bodingbauer is currently working as a Associate Professor in the Department of Department of Surgery (Division of General Surgery), Medical University of Vienna , Â Austria. His research interests includes General Surgery. He /she is serving as an editorial member and reviewer of several international reputed journals. Dr. Martin Bodingbauer is the member of many international affiliations. He/ She has successfully completed his Administrative responsibilities. He /she has authored of many research articles/books related to General Surgery.
Research Interest
I´m a surgical oncologist with special training in hepatobiliary surgery to treat benign and malignant diseases of the liver, gallbladder and bile ducts. This encompasses a wide spectrum of diseases such as cancer, cysts and lesions, gallstones, stricture and bile leaks. My main research interest is to assess the impact of neoadjuvant chemotherapy on patients with colorectal cancer liver metastases on liver function and clinical outcome after liver resection. A further research focus is safety of liver resection for HCC (Hepatocellular Carcinoma) in patients with portal hypertension defined as 90 days postoperative morbidity and mortality and to find new predictive markers for liver decompensation.
Publications
-
The effect of steroid pretreatment of deceased organ donors on liver allograft function: a blinded randomized placebo-controlled trial. Amatschek S, Wilflingseder J, Pones M, Kainz A, Bodingbauer M, Mühlbacher F, Langer RM, Gerlei Z, Oberbauer R. J Hepatol. 2012 Jun;56(6):1305-9.
-
Transection Speed and Impact on Perioperative Inflammatory Response - A Randomized Controlled Trial Comparing Stapler Hepatectomy and CUSA Resection. Schwarz C, Klaus DA, Tudor B, Fleischmann E, Wekerle T, Roth G, Bodingbauer M, Kaczirek K. PLoS One. 2015 Oct 9;10(10)
-
Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases. Wimmer K, Schwarz C, Szabo C, Bodingbauer M, Tamandl D, Mittlböck M, Kaczirek K. Ann Surg Oncol. 2017 Jan;24(1):236-243
